Skip to content
lifestyle.the-newshub.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Jade Biosciences
Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody
May 31, 2026
Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy
May 30, 2026
Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 28, 2026
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 26, 2026
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
May 25, 2026
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
April 28, 2026
Jade Biosciences to Participate in Upcoming Conferences
February 13, 2026